MC
DRTSW icon

Meteora Capital’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Meteora Capital’s Portfolio DRTSW Stock Details DRTSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-980
Closed -$333 – 397
2025
Q4 		$333 Buy
+980
New +$330 ﹤0.01% 364

Other funds holding DRTSW

FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
VB
Value Base Tel Aviv, Israel $162M AUM 2.31% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
ICM
Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return

Meteora Capital's DRTSW Position: Q1 2026 in Review

Meteora Capital sold out of Alpha Tau Medical Warrant (DRTSW) in Q1 2026, closing a stake of 980 shares — an estimated $333 sold.

Meteora Capital first reported a position in DRTSW in Q4 2025 and held it in 1 quarter. The position peaked at $333 in Q4 2025. 21 funds tracked by Wall St. Rank hold DRTSW as of Q1 2026.

  • Meteora Capital reported no remaining Alpha Tau Medical Warrant position as of Q1 2026 after selling out during the quarter.
  • Meteora Capital sold 980 Alpha Tau Medical Warrant shares in Q1 2026, an estimated $333.
  • Meteora Capital first reported a position in Alpha Tau Medical Warrant in Q4 2025 and held it in 1 quarter.
  • Meteora Capital's Alpha Tau Medical Warrant position peaked at $333 in Q4 2025.
  • 21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q1 2026.

Based on Meteora Capital's 13F filing for Q1 2026, filed 15 May 2026.